14 active trials 5 recruiting 2 Phase 3 8 disease areas
| Phase 1 | 7 | |
| Phase 1/2 | 2 | |
| Phase 2 | 2 | |
| Phase 3 | 2 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06426485 | To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride… | Major Depressive Disorder | Not Yet Recruiting | 2024-05-23 |
| Phase 3 | ||||
| NCT06496048 | Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with… | Relapsed Small Cell Lung Cancer | Recruiting | 2024-12-12 |
| NCT06128837 | Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer | Relapsed Small Cell Lung Cancer | Recruiting | 2024-03-15 |
| Phase 2 | ||||
| NCT07396870 | A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic… | Schizophrenia | Not Yet Recruiting | 2026-02-09 |
| NCT07236476 | Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for… | Assisted Reproduction | Active, Not Recruiting | 2025-11-19 |
| Phase 1/2 | ||||
| NCT06731868 | Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive… | Tardive Dyskinesia (TD) | Recruiting | 2025-01-22 |
| NCT07391566 | LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal… | Metastatic Colorectal Cancer (mCRC) | Not Yet Recruiting | 2026-02-06 |
| Phase 1 | ||||
| NCT07230652 | A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 | Schizophrenia | Recruiting | 2025-11-19 |
| NCT06240546 | First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors. | Advanced Solid Tumor | Recruiting | 2024-03-15 |
| NCT07516899 | Mass Balance Study of [14C] LPM3770164 in Healthy Participants | Huntington Disease | Not Yet Recruiting | 2026-04-08 |
| NCT07371065 | To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of… | Major Depressive Disorder | Enrolling by Invitation | 2026-01-27 |
| NCT07292233 | A Food Effect Study of LY03020 in Healthy Subjects | Schizophrenia | Active, Not Recruiting | 2025-12-18 |
| NCT06980207 | A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 | Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis | Not Yet Recruiting | 2025-05-20 |
| NCT06793995 | Effect of Food and Age on the Pharmacokinetics of LY03017 | Alzheimer's Disease Psychosis | Not Yet Recruiting | 2025-01-27 |
Schizophrenia (5) · Alzheimer's Disease (4) · Depression (2) · Lung Cancer (2) · Parkinson's Disease (2) · Small Cell Lung Cancer (2) · Colorectal Cancer (1) · Huntington's Disease (1)